MedTrace Logo

Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia

NCT00899119 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2013-12-18

No results posted yet for this study

Summary

RATIONALE: Collecting and storing stem cells to study in the laboratory may help doctors learn more about collecting stem cells from patients who have undergone treatment for Waldenstrom's macroglobulinemia.

PURPOSE: This laboratory study is collecting stem cells from patients with Waldenstrom's macroglobulinemia.

Conditions

Interventions

PROCEDURE

leukapheresis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Herbert Irving Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Gwen L. Nichols, MD · Herbert Irving Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00899119 on ClinicalTrials.gov